InvestorsHub Logo
Followers 3
Posts 288
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Friday, 06/30/2023 10:54:54 AM

Friday, June 30, 2023 10:54:54 AM

Post# of 110
Stifel upgraded Black Diamond Therapeutics (BDTX) to Buy from Hold with a price target of $10, up from $2, following the company's BDTX-1535 phase 1 data released this week. Compared to novel developments that have modest monotherapy efficacy in 2L post-Tagrisso and are forced into combinations or lengthy randomized trials, the BDTX-1535 effect size may potentially allow for rapid monotherapy regulatory paths, the firm says.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BDTX News